Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epalrestat in Diabetic Peripheral Neuropathy and CNS Effects
NCT05184049Phase 4Unknown
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Jan 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of epalrestat in diabetic peripheral neuropathy (DPN), sponsored by Xiangya Hospital, Central South University. Status: unknown.
02
Drugs
epalrestat
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT05184049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05184049.